ABEONA THERAPEUTICS INC. Operating Income
ABEONA THERAPEUTICS INC. (ABEO) reported Operating Income of -$13.65 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-13
- ABEONA THERAPEUTICS INC. operating income (loss) for the quarter ending 2026-06-30 was -$13.65M.
- ABEONA THERAPEUTICS INC. operating income (loss) for the quarter ending 2026-03-31 was -$23.03M.
- ABEONA THERAPEUTICS INC. operating income (loss) for the quarter ending 2025-12-31 was -$22.91M.
- ABEONA THERAPEUTICS INC. operating income (loss) for the quarter ending 2025-09-30 was -$24.02M.
- ABEONA THERAPEUTICS INC. operating income (loss) for fiscal 2025 was -$89.45M.
- ABEONA THERAPEUTICS INC. operating income (loss) for fiscal 2024 was -$64.21M.
- ABEONA THERAPEUTICS INC. operating income (loss) for fiscal 2023 was -$47.13M.
- ABEONA THERAPEUTICS INC. operating income (loss) for fiscal 2022 was -$50.91M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$13.65M 10-Q · filed 2026-08-13 | -$36.69M 10-Q · filed 2026-08-13 | -$59.60M derived: sum of 3 quarters · filed 2026-08-13 | -$83.61M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2026-03-31 | -$23.03M 10-Q · filed 2026-05-13 | -$45.94M derived: sum of 2 quarters · filed 2026-05-13 | -$69.96M derived: sum of 3 quarters · filed 2026-05-13 | -$92.75M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-12-31 | -$22.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | -$46.93M derived: sum of 2 quarters · filed 2026-03-17 | -$69.72M derived: sum of 3 quarters · filed 2026-08-13 | -$89.45M 10-K · filed 2026-03-17 | |||
| 2025-09-30 | -$24.02M 10-Q · filed 2025-11-12 | -$46.81M derived: sum of 2 quarters · filed 2026-08-13 | -$66.54M 10-Q · filed 2025-11-12 | -$83.21M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-06-30 | -$22.79M 10-Q · filed 2026-08-13 | -$42.52M 10-Q · filed 2026-08-13 | -$59.19M derived: sum of 3 quarters · filed 2026-08-13 | -$74.54M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-03-31 | -$19.73M 10-Q · filed 2026-05-13 | -$36.40M derived: sum of 2 quarters · filed 2026-05-13 | -$51.74M derived: sum of 3 quarters · filed 2026-05-13 | -$69.61M derived: sum of 4 quarters · filed 2026-05-13 | |||
| 2024-12-31 | -$16.67M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | -$32.02M derived: sum of 2 quarters · filed 2026-03-17 | -$49.88M derived: sum of 3 quarters · filed 2026-03-17 | -$64.21M 10-K · filed 2026-03-17 | |||
| 2024-09-30 | -$15.35M 10-Q · filed 2025-11-12 | -$33.21M derived: sum of 2 quarters · filed 2025-11-12 | -$47.54M 10-Q · filed 2025-11-12 | -$60.75M derived: sum of 4 quarters · filed 2025-11-12 | |||
| 2024-06-30 | -$17.86M 10-Q · filed 2025-08-14 | -$32.19M 10-Q · filed 2025-08-14 | -$45.40M derived: sum of 3 quarters · filed 2025-08-14 | -$56.74M derived: sum of 4 quarters · filed 2025-08-14 | |||
| 2024-03-31 | -$14.33M 10-Q · filed 2025-05-15 | -$27.54M derived: sum of 2 quarters · filed 2025-05-15 | -$38.87M derived: sum of 3 quarters · filed 2025-05-15 | -$49.43M derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | -$13.21M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$24.54M derived: sum of 2 quarters · filed 2025-03-20 | -$35.10M derived: sum of 3 quarters · filed 2025-03-20 | -$47.13M 10-K · filed 2025-03-20 | |||
| 2023-09-30 | -$11.33M 10-Q · filed 2024-11-14 | -$21.89M derived: sum of 2 quarters · filed 2024-11-14 | -$33.93M 10-Q · filed 2024-11-14 | -$46.86M derived: sum of 4 quarters · filed 2024-11-14 | |||
| 2023-06-30 | -$10.55M 10-Q · filed 2024-08-12 | -$22.59M 10-Q · filed 2024-08-12 | -$35.53M derived: sum of 3 quarters · filed 2024-08-12 | -$44.91M derived: sum of 4 quarters · filed 2024-08-12 | |||
| 2023-03-31 | -$12.04M 10-Q · filed 2024-05-15 | -$24.97M derived: sum of 2 quarters · filed 2024-05-15 | -$34.35M derived: sum of 3 quarters · filed 2024-05-15 | -$42.36M derived: sum of 4 quarters · filed 2024-05-15 | |||
| 2022-12-31 | -$12.94M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | -$22.32M derived: sum of 2 quarters · filed 2024-03-18 | -$30.32M derived: sum of 3 quarters · filed 2024-03-18 | -$50.91M 10-K · filed 2024-03-18 | |||
| 2022-09-30 | -$9.38M 10-Q · filed 2023-11-13 | -$17.39M derived: sum of 2 quarters · filed 2023-11-13 | -$37.98M 10-Q · filed 2023-11-13 | -$84.63M derived: sum of 4 quarters · filed 2023-11-13 | |||
| 2022-06-30 | -$8.01M 10-Q · filed 2023-08-08 | -$28.60M 10-Q · filed 2023-08-08 | -$75.25M derived: sum of 3 quarters · filed 2023-08-08 | -$90.12M derived: sum of 4 quarters · filed 2023-08-08 | |||
| 2022-03-31 | -$20.59M 10-Q · filed 2023-05-11 | -$67.24M derived: sum of 2 quarters · filed 2023-05-11 | -$82.11M derived: sum of 3 quarters · filed 2023-05-11 | -$95.83M derived: sum of 4 quarters · filed 2023-05-11 | |||
| 2021-12-31 | -$46.65M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | -$61.52M derived: sum of 2 quarters · filed 2023-03-29 | -$75.24M derived: sum of 3 quarters · filed 2023-03-29 | -$89.84M 10-K · filed 2023-03-29 | |||
| 2021-09-30 | -$14.87M 10-Q · filed 2022-11-14 | -$28.59M derived: sum of 2 quarters · filed 2022-11-14 | -$43.18M 10-Q · filed 2022-11-14 | -$57.66M derived: sum of 4 quarters · filed 2022-11-14 | |||
| 2021-06-30 | -$13.71M 10-Q · filed 2022-08-11 | -$28.31M 10-Q · filed 2022-08-11 | -$42.79M derived: sum of 3 quarters · filed 2022-08-11 | -$49.04M derived: sum of 4 quarters · filed 2022-08-11 | |||
| 2021-03-31 | -$14.60M 10-Q · filed 2022-05-13 | -$29.08M derived: sum of 2 quarters · filed 2022-05-13 | -$35.33M derived: sum of 3 quarters · filed 2022-05-13 | -$47.81M derived: sum of 4 quarters · filed 2022-05-13 | |||
| 2020-12-31 | -$14.48M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$20.73M derived: sum of 2 quarters · filed 2022-03-31 | -$33.21M derived: sum of 3 quarters · filed 2022-03-31 | -$81.42M 10-K · filed 2022-03-31 | |||
| 2020-09-30 | -$6.25M 10-Q · filed 2021-11-15 | -$18.73M derived: sum of 2 quarters · filed 2021-11-15 | -$66.94M 10-Q · filed 2021-11-15 | -$83.35M derived: sum of 4 quarters · filed 2021-11-15 | |||
| 2020-06-30 | -$12.48M 10-Q · filed 2021-07-28 | -$60.69M 10-Q · filed 2021-07-28 | -$77.10M derived: sum of 3 quarters · filed 2021-07-28 | -$94.75M derived: sum of 4 quarters · filed 2021-07-28 | |||
| 2020-03-31 | -$48.21M 10-Q · filed 2021-05-17 | -$64.62M derived: sum of 2 quarters · filed 2021-05-17 | -$82.27M derived: sum of 3 quarters · filed 2021-05-17 | -$106.25M derived: sum of 4 quarters · filed 2021-05-17 | |||
| 2019-12-31 | -$16.41M 10-K · filed 2020-03-16 | -$34.06M derived: sum of 2 quarters · filed 2020-11-09 | -$58.04M derived: sum of 3 quarters · filed 2020-11-09 | -$77.09M 10-K · filed 2021-03-24 | |||
| 2019-09-30 | -$17.65M 10-Q · filed 2020-11-09 | -$41.63M derived: sum of 2 quarters · filed 2020-11-09 | -$60.68M 10-Q · filed 2020-11-09 | -$78.69M derived: sum of 4 quarters · filed 2020-11-09 | |||
| 2019-06-30 | -$23.98M 10-Q · filed 2020-08-10 | -$43.03M 10-Q · filed 2020-08-10 | -$61.04M derived: sum of 3 quarters · filed 2020-08-10 | -$77.96M derived: sum of 4 quarters · filed 2020-08-10 | |||
| 2019-03-31 | -$19.05M 10-Q · filed 2020-05-06 | -$37.06M derived: sum of 2 quarters · filed 2020-05-06 | -$53.98M derived: sum of 3 quarters · filed 2020-05-06 | -$66.54M derived: sum of 4 quarters · filed 2020-05-06 | |||
| 2018-12-31 | -$18.01M 10-K · filed 2020-03-16 | -$34.93M derived: sum of 2 quarters · filed 2020-03-16 | -$47.48M derived: sum of 3 quarters · filed 2020-03-16 | -$58.17M 10-K · filed 2020-03-16 | |||
| 2018-09-30 | -$16.92M 10-K · filed 2020-03-16 | -$29.47M derived: sum of 2 quarters · filed 2020-03-16 | -$40.16M 10-Q · filed 2019-11-12 | -$37.55M 10-Q · filed 2018-11-09 | -$48.91M derived: sum of 4 quarters · filed 2020-03-16 | ||
| 2018-06-30 | -$12.56M 10-K · filed 2020-03-16 | -$12.01M 10-Q · filed 2018-08-09 | -$23.24M 10-Q · filed 2019-08-09 | -$20.63M 10-Q · filed 2018-08-09 | -$31.99M derived: sum of 3 quarters · filed 2020-03-16 | -$37.35M derived: sum of 4 quarters · filed 2020-03-16 | |
| 2018-03-31 | -$10.68M 10-K · filed 2020-03-16 | -$8.62M 10-Q · filed 2018-05-10 | -$19.43M derived: sum of 2 quarters · filed 2020-03-16 | -$24.80M derived: sum of 3 quarters · filed 2020-03-16 | -$33.23M derived: sum of 4 quarters · filed 2020-03-16 | ||
| 2017-12-31 | -$8.75M 10-K · filed 2019-03-18 | -$14.11M derived: sum of 2 quarters · filed 2019-03-18 | -$22.55M derived: sum of 3 quarters · filed 2019-03-18 | -$27.84M 10-K · filed 2020-03-16 | |||
| 2017-09-30 | -$5.36M 10-K · filed 2019-03-18 | -$13.80M derived: sum of 2 quarters · filed 2019-03-18 | -$19.09M 10-Q · filed 2018-11-09 | -$24.92M derived: sum of 4 quarters · filed 2019-03-18 | |||
| 2017-06-30 | -$8.44M 10-K · filed 2019-03-18 | -$13.72M 10-Q · filed 2018-08-09 | -$19.56M derived: sum of 3 quarters · filed 2019-03-18 | -$24.73M derived: sum of 4 quarters · filed 2019-03-18 | |||
| 2017-03-31 | -$5.28M 10-K · filed 2019-03-18 | -$11.12M derived: sum of 2 quarters · filed 2019-03-18 | -$16.29M derived: sum of 3 quarters · filed 2019-03-18 | -$23.00M derived: sum of 4 quarters · filed 2019-03-18 | |||
| 2016-12-31 | -$5.83M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | -$11.01M derived: sum of 2 quarters · filed 2019-03-18 | -$17.72M derived: sum of 3 quarters · filed 2019-03-18 | -$23.88M 10-K · filed 2019-03-18 | |||
| 2016-09-30 | -$5.17M 10-Q · filed 2017-11-14 | -$11.89M derived: sum of 2 quarters · filed 2017-11-14 | -$18.05M 10-Q · filed 2017-11-14 | -$24.30M derived: sum of 4 quarters · filed 2017-11-14 | |||
| 2016-06-30 | -$6.71M 10-Q · filed 2017-08-14 | -$12.88M 10-Q · filed 2017-08-14 | -$19.13M derived: sum of 3 quarters · filed 2017-08-14 | -$25.29M derived: sum of 4 quarters · filed 2017-08-14 | |||
| 2016-03-31 | -$6.16M 10-Q · filed 2017-05-15 | -$12.41M derived: sum of 2 quarters · filed 2017-05-15 | -$18.58M derived: sum of 3 quarters · filed 2017-05-15 | -$22.70M derived: sum of 4 quarters · filed 2017-05-15 | |||
| 2015-12-31 | -$6.25M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | -$12.42M derived: sum of 2 quarters · filed 2017-03-30 | -$16.54M derived: sum of 3 quarters · filed 2017-03-30 | -$18.55M 10-K · filed 2017-03-30 | |||
| 2015-09-30 | -$6.16M 10-Q · filed 2016-11-14 | -$10.29M derived: sum of 2 quarters · filed 2016-11-14 | -$12.29M 10-Q · filed 2016-11-14 | -$12.76M derived: sum of 4 quarters · filed 2016-11-14 | |||
| 2015-06-30 | -$4.13M 10-Q · filed 2016-08-15 | -$6.13M 10-Q · filed 2016-08-15 | -$6.60M derived: sum of 3 quarters · filed 2016-08-15 | -$7.23M derived: sum of 4 quarters · filed 2016-08-15 | |||
| 2015-03-31 | -$2.00M 10-Q · filed 2016-05-16 | -$2.47M derived: sum of 2 quarters · filed 2016-05-16 | -$3.10M derived: sum of 3 quarters · filed 2016-05-16 | -$3.81M derived: sum of 4 quarters · filed 2016-05-16 | |||
| 2014-12-31 | -$467.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | -$1.10M derived: sum of 2 quarters · filed 2016-03-30 | -$1.80M derived: sum of 3 quarters · filed 2016-03-30 | -$3.13M 10-K · filed 2016-03-30 | |||
| 2014-09-30 | -$633.00K 10-Q · filed 2015-11-16 | -$1.34M derived: sum of 2 quarters · filed 2015-11-16 | -$2.66M 10-Q · filed 2015-11-16 | -$3.35M derived: sum of 4 quarters · filed 2015-11-16 | |||
| 2014-06-30 | -$703.00K 10-Q · filed 2015-08-14 | -$2.03M 10-Q · filed 2015-08-14 | -$2.71M derived: sum of 3 quarters · filed 2015-08-14 | -$3.41M derived: sum of 4 quarters · filed 2015-08-14 | |||
| 2014-03-31 | -$1.33M 10-Q · filed 2015-05-14 | -$597.00K 10-Q · filed 2014-05-12 | -$2.01M derived: sum of 2 quarters · filed 2015-05-14 | -$2.71M derived: sum of 3 quarters · filed 2015-05-14 | -$4.63M derived: sum of 4 quarters · filed 2015-05-14 | ||
| 2013-12-31 | -$684.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | -$1.38M derived: sum of 2 quarters · filed 2015-03-31 | -$3.30M derived: sum of 3 quarters · filed 2015-03-31 | -$3.80M 10-K · filed 2015-03-31 | |||
| 2013-09-30 | -$696.00K 10-Q · filed 2014-11-14 | -$2.62M derived: sum of 2 quarters · filed 2014-11-14 | -$3.12M 10-Q · filed 2014-11-14 | -$4.34M derived: sum of 4 quarters · filed 2014-11-14 | |||
| 2013-06-30 | -$1.92M 10-Q · filed 2014-08-14 | -$2.42M 10-Q · filed 2014-08-14 | -$3.64M derived: sum of 3 quarters · filed 2014-08-14 | -$4.60M derived: sum of 4 quarters · filed 2014-08-14 | |||
| 2013-03-31 | -$503.00K 10-Q · filed 2014-05-12 | -$1.72M derived: sum of 2 quarters · filed 2014-05-12 | -$2.68M derived: sum of 3 quarters · filed 2014-05-12 | -$4.13M derived: sum of 4 quarters · filed 2014-05-12 | |||
| 2012-12-31 | -$1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26 | -$2.17M derived: sum of 2 quarters · filed 2014-03-26 | -$3.63M derived: sum of 3 quarters · filed 2014-03-26 | -$4.32M 10-K · filed 2014-03-26 | |||
| 2012-09-30 | -$956.00K 10-Q · filed 2013-11-14 | -$2.41M derived: sum of 2 quarters · filed 2013-11-14 | -$3.10M 10-Q · filed 2013-11-14 | -$4.79M derived: sum of 4 quarters · filed 2013-11-14 | |||
| 2012-06-30 | -$1.45M 10-Q · filed 2013-08-14 | -$2.14M 10-Q · filed 2013-08-14 | -$3.83M derived: sum of 3 quarters · filed 2013-08-14 | -$5.62M derived: sum of 4 quarters · filed 2013-08-14 | |||
| 2012-03-31 | -$689.00K 10-Q · filed 2013-05-15 | -$2.38M derived: sum of 2 quarters · filed 2013-05-15 | -$4.16M derived: sum of 3 quarters · filed 2013-05-15 | -$6.42M derived: sum of 4 quarters · filed 2013-05-15 | |||
| 2011-12-31 | -$1.69M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-20 | -$3.47M derived: sum of 2 quarters · filed 2013-03-20 | -$5.73M derived: sum of 3 quarters · filed 2013-03-20 | -$7.88M 10-K · filed 2013-03-20 | |||
| 2011-09-30 | -$1.78M 10-Q · filed 2012-11-14 | -$4.04M derived: sum of 2 quarters · filed 2012-11-14 | -$6.19M 10-Q · filed 2012-11-14 | ||||
| 2011-06-30 | -$2.25M 10-Q · filed 2012-08-14 | -$4.40M 10-Q · filed 2012-08-14 | |||||
| 2011-03-31 | -$2.15M 10-Q · filed 2012-05-15 | ||||||
| 2010-12-31 | -$7.76M 10-K · filed 2012-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |